From: Development of a new stroke scale in an emergency setting
Variables | Stroke n = 358 | Non-stroke n = 58 | P |
---|---|---|---|
Age | 69.2 ± 13.8 | 70.6 ± 11.4 | 0.397 |
Male, n (%) | 210 (58.7) | 37 (63.8) | 0.460 |
SBP, mmHg | 168.8 ± 31.9 | 147.8 ± 27.6 | <0.001* |
DBP, mmHg | 91.8 ± 20.7 | 80.8 ± 14.3 | <0.001* |
bpm | 80.9 ± 18.1 | 80.0 ± 13.3 | 0.742 |
Medical history, n (%) | |||
 Smoker | 146 (40.8) | 20 (34.5) | 0.339 |
 Hypertension | 202 (56.4) | 34 (58.6) | 0.992 |
 Diabetes | 58 (16.2) | 14 (24.1) | 0.157 |
 Hyperlipidemia | 40 (11.2) | 9 (15.5) | 0.407 |
 Ischemic heart disease | 36 (10.1) | 8 (13.8) | 0.434 |
 Atrial fibrillation | 28 (7.8) | 1 (1.7) | 0.148 |
Symptoms & signs, n (%) | |||
 Asymmetric facial weakness | 181 (50.6) | 8 (13.8) | <0.001* |
 Asymmetric arm weakness | 217 (60.6) | 7 (12.1) | <0.001* |
 Asymmetric leg weakness | 228 (63.7) | 9 (15.5) | <0.001* |
 Speech disturbance | 195 (54.5) | 17 (29.3) | <0.001* |
 Visual field defect | 68 (19.0) | 1 (1.7) | 0.001* |
 gaze palsy | 115 (32.1) | 5 (8.6) | <0.001* |
 Sensory deficits | 78 (21.8) | 8 (13.8) | 0.163 |
 Loss of consciousness or syncope | 119 (33.2) | 10 (17.2) | 0.015* |
 Seizure activity | 21 (5.9) | 6 (10.3) | 0.319 |
 Pathologic reflex | 102 (28.5) | 8 (13.8) | 0.019* |
 Meningeal irritation | 22 (6.1) | 0 (0) | 0.102 |
 Vertigo | 26 (7.3) | 19 (32.8) | <0.001* |
 Headache | 25 (7.0) | 3 (5.2) | 0.816 |
 Nausea | 59 (16.5) | 26 (44.8) | <0.001* |
 Vomiting | 51 (14.2) | 23 (39.7) | <0.001* |
Score | |||
 GCS > 8, n (%) | 297 (83) | 56 (96.6) | 0.007* |
 GCS ≤ 8, n (%) | 61 (17) | 2 (3.4) | 0.007* |
 GCS, median (IQR) | 15 (12–15) | 15 (15–15) | <0.001* |